Search This Blog

Thursday, May 2, 2019

Teva sees free cash flow stronger in second half of 2019

Sees FY19 free cash flow $1.6B-$2B. Comments from Q1 earnings conference call.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.